PH12019500714A1 - Antiseptic-tolerant lactic acid bacteria - Google Patents
Antiseptic-tolerant lactic acid bacteriaInfo
- Publication number
- PH12019500714A1 PH12019500714A1 PH12019500714A PH12019500714A PH12019500714A1 PH 12019500714 A1 PH12019500714 A1 PH 12019500714A1 PH 12019500714 A PH12019500714 A PH 12019500714A PH 12019500714 A PH12019500714 A PH 12019500714A PH 12019500714 A1 PH12019500714 A1 PH 12019500714A1
- Authority
- PH
- Philippines
- Prior art keywords
- lactic acid
- acid bacteria
- antiseptic
- strains
- tolerant lactic
- Prior art date
Links
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title abstract 8
- 241000894006 Bacteria Species 0.000 title abstract 4
- 235000014655 lactic acid Nutrition 0.000 title abstract 4
- 239000004310 lactic acid Substances 0.000 title abstract 4
- 241000192001 Pediococcus Species 0.000 abstract 1
- 241000191998 Pediococcus acidilactici Species 0.000 abstract 1
- 230000002421 anti-septic effect Effects 0.000 abstract 1
- 229940064004 antiseptic throat preparations Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 229940127557 pharmaceutical product Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- General Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- Birds (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Immunology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16382453 | 2016-10-03 | ||
| PCT/EP2017/074844 WO2018065324A1 (en) | 2016-10-03 | 2017-09-29 | Antiseptic-tolerant lactic acid bacteria |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH12019500714A1 true PH12019500714A1 (en) | 2019-08-05 |
Family
ID=57123946
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH12019500714A PH12019500714A1 (en) | 2016-10-03 | 2019-04-02 | Antiseptic-tolerant lactic acid bacteria |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US10850135B2 (enExample) |
| EP (1) | EP3519557A1 (enExample) |
| JP (1) | JP7068286B2 (enExample) |
| KR (1) | KR102476856B1 (enExample) |
| CN (1) | CN109890955B (enExample) |
| AU (1) | AU2017339033B2 (enExample) |
| CA (1) | CA3038868A1 (enExample) |
| EA (1) | EA201990630A1 (enExample) |
| MX (1) | MX379324B (enExample) |
| MY (1) | MY191734A (enExample) |
| PH (1) | PH12019500714A1 (enExample) |
| WO (1) | WO2018065324A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102036275B1 (ko) * | 2018-10-02 | 2019-10-24 | 서울대학교 산학협력단 | 항-염증 활성이 우수한 페디오코커스 악시딜락티시 ldtm 5201 신균주(kctc 13563bp) |
| CN110819558B (zh) * | 2019-10-16 | 2022-07-05 | 天津科技大学 | 一种乳酸片球菌aaf 3-3及其用途 |
| WO2021183085A2 (en) * | 2020-03-12 | 2021-09-16 | Hly Aromaterapi̇ Hi̇zmetleri̇ Kozmeti̇k Sanayi̇ Ti̇caret Anoni̇m Şi̇rketi̇ | Probiotic and oil combination |
| TWI748395B (zh) * | 2020-03-31 | 2021-12-01 | 豐華生物科技股份有限公司 | 緩解過敏以及提升運動表現之組合物及其用途 |
| TR202006605A2 (tr) * | 2020-04-28 | 2020-06-22 | Hly Aromaterapi Hizmetleri Kozmetik Sanayi Ticaret Anonim Sirketi | Aynisefa yaği i̇çeren multi̇ probi̇yoti̇k yağ kombi̇nasyonu ve üreti̇m yöntemi̇ |
| WO2021221594A2 (en) * | 2020-04-30 | 2021-11-04 | Hly Aromaterapi̇ Hi̇zmetleri̇ Kozmeti̇k Sanayi̇ Ti̇caret Anoni̇m Şi̇rketi̇ | Multi-probiotic oil combination containing borage oil and production method thereof |
| CN111826324A (zh) * | 2020-08-05 | 2020-10-27 | 厦门惠盈动物科技有限公司 | 一种鼠李糖乳杆菌菌粉的制备方法 |
| JP2024506463A (ja) * | 2021-01-05 | 2024-02-14 | ラクトバイオ アー／エス | 菌株、組成物および使用方法 |
| CN112675182A (zh) * | 2021-01-14 | 2021-04-20 | 吉林大学 | 水杨酸甲酯在制备沙门氏菌ⅲ型分泌系统抑制剂中的应用 |
| KR102562773B1 (ko) * | 2021-07-05 | 2023-08-02 | 동국대학교 산학협력단 | 페디오코쿠스 에시디락티시의 gDNA를 포함하는 구강 염증 질환 예방 또는 치료용 약학 조성물 |
| AU2023233349A1 (en) * | 2022-03-17 | 2024-10-10 | Kaneka Corporation | Glucuronidase activator, pharmaceutical composition, edible composition, and composition for oral application |
| JP2023172607A (ja) * | 2022-05-24 | 2023-12-06 | 株式会社アデランス | 乳酸菌含有ガム |
| CN116464031A (zh) * | 2023-04-19 | 2023-07-21 | 海南大学 | 一种岛礁珊瑚填料挤密桩及其施工方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0303678D0 (en) | 2003-02-18 | 2003-03-19 | Quest Int | Improvements in or relating to flavour compositions |
| KR20110019803A (ko) | 2009-08-21 | 2011-03-02 | 신미정 | 향이 첨가된 치주 질환의 예방 및 치료용 유산균 분말 세정제 |
| DE202009011379U1 (de) * | 2009-08-24 | 2010-12-30 | Khalifa, Samir | Orale Präparate zur Mund- und Zahnpflege und Bekämpfung von Mundgeruch |
| EP2420580A1 (en) | 2010-08-18 | 2012-02-22 | AB-Biotics, S.A. | Probiotic composition for oral health |
| KR101804145B1 (ko) * | 2013-08-14 | 2017-12-04 | 울산과학기술원 | 대장균의 지놈 엔지니어링용 플라스미드 및 이를 이용한 대장균의 지놈 엔지니어링 방법 |
| US9554986B2 (en) * | 2014-07-30 | 2017-01-31 | Nelson Harvey | Oral care composition |
| EP3117822A1 (en) | 2015-07-17 | 2017-01-18 | AB-Biotics, S.A. | Self-film-forming composition for oral care |
-
2017
- 2017-09-29 MX MX2019003787A patent/MX379324B/es unknown
- 2017-09-29 WO PCT/EP2017/074844 patent/WO2018065324A1/en not_active Ceased
- 2017-09-29 KR KR1020197012095A patent/KR102476856B1/ko active Active
- 2017-09-29 EP EP17784224.2A patent/EP3519557A1/en active Pending
- 2017-09-29 JP JP2019517937A patent/JP7068286B2/ja active Active
- 2017-09-29 US US16/338,745 patent/US10850135B2/en active Active
- 2017-09-29 AU AU2017339033A patent/AU2017339033B2/en active Active
- 2017-09-29 MY MYPI2019001837A patent/MY191734A/en unknown
- 2017-09-29 CN CN201780066547.3A patent/CN109890955B/zh active Active
- 2017-09-29 EA EA201990630A patent/EA201990630A1/ru unknown
- 2017-09-29 CA CA3038868A patent/CA3038868A1/en active Pending
-
2019
- 2019-04-02 PH PH12019500714A patent/PH12019500714A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2017339033B2 (en) | 2024-04-18 |
| AU2017339033A1 (en) | 2019-04-18 |
| CN109890955A (zh) | 2019-06-14 |
| KR20190062477A (ko) | 2019-06-05 |
| MX2019003787A (es) | 2019-09-26 |
| WO2018065324A1 (en) | 2018-04-12 |
| US20190247681A1 (en) | 2019-08-15 |
| BR112019006653A2 (pt) | 2019-07-02 |
| CN109890955B (zh) | 2023-05-09 |
| JP7068286B2 (ja) | 2022-05-16 |
| EA201990630A1 (ru) | 2019-10-31 |
| MX379324B (es) | 2025-03-11 |
| CA3038868A1 (en) | 2018-04-12 |
| JP2019533655A (ja) | 2019-11-21 |
| US10850135B2 (en) | 2020-12-01 |
| EP3519557A1 (en) | 2019-08-07 |
| MY191734A (en) | 2022-07-13 |
| KR102476856B1 (ko) | 2022-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12019500714A1 (en) | Antiseptic-tolerant lactic acid bacteria | |
| WO2015114666A3 (en) | Treatments for resistant acne | |
| NZ737752A (en) | Compositions comprising bacterial strains | |
| EA201391500A1 (ru) | Синергический противомикробный эффект | |
| BR112013016493A2 (pt) | uso de um microrganismo com capacidade de ligação ou fragmento deste, método de preparar uma composição, composição, e, microrganismo com capacidade de ligação ou fragmento deste | |
| MX2016014807A (es) | Singenes de alfa(1,2)fucosiltransferasa para su utilizacion en la produccion de oligosacaridos fucosilados. | |
| MX367109B (es) | Composiciones bacterianas sinergicas y sus metodos de produccion y usos. | |
| WO2017017631A3 (en) | Antibacterial therapeutics and prophylactics | |
| NZ715667A (en) | Oral compositions | |
| MX2023002516A (es) | Composiciones bacterianas. | |
| RU2013114313A (ru) | Противокариесные композиции и пробиотики/пребиотики | |
| WO2015092548A3 (en) | Paenibacillus strains and compositions thereof that inhibit microorganisms | |
| MX2016010451A (es) | Benzoxaboroles microbicidamente activos. | |
| TN2016000435A1 (en) | Novel macrocyclic compounds. | |
| WO2016057413A3 (en) | Inhibitors of lysine gingipain | |
| MX2016012915A (es) | Profarmacos de inhibidores de la transcriptasa inversa del virus de la inmunodeficiencia humana (vih). | |
| PH12017500059A1 (en) | Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | |
| PH12017500971A1 (en) | Synergistic bacterial consortia for mobilizing soil phosphorus | |
| MX2019005535A (es) | Streptococcus thermophilus para uso en la preparación de productos fermentados. | |
| MX2020001199A (es) | Compuestos y composiciones farmaceuticas de los mismos para usarse en el tratamiento de enfermedades fibroticas. | |
| SG10201805890QA (en) | Compositions and methods for treatment of abnormal cell growth | |
| MX2017007969A (es) | Bacterias de acido lactico y su uso para el tratamiento de mastitis. | |
| MX2018011095A (es) | Compuestos de carbapenem. | |
| PH12022550952A1 (en) | Antimicrobial compositions comprising modified clay and copolymers | |
| WO2015035234A3 (en) | Anti-microbial compounds and compositions |